The Current Ratio as of December 2025 (TTM) for Neurogene Inc. (NGNE) is 18.39

According to Neurogene Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 18.39. This represents a change of -6.09% compared to the average of 19.58 of the last 4 quarters.

Neurogene Inc. (NGNE) Historical Current Ratio (quarterly & annually)

How has NGNE Current Ratio performed in the past?

The mean historical Current Ratio of Neurogene Inc. over the last ten years is 15.71. The current 18.39 Current Ratio has changed 11.60% with respect to the historical average. Over the past ten years (40 quarters), NGNE's Current Ratio was at its highest in in the June 2019 quarter at 63.17. The Current Ratio was at its lowest in in the June 2018 quarter at 7.73.

Neurogene Inc. (NGNE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Neurogene Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neurogene Inc. (NGNE) Average Current Ratio

How has NGNE Current Ratio performed in the past?

The current Current Ratio of Neurogene Inc. (NGNE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Neurogene Inc. (NGNE) Current Ratio vs. Peers

How is NGNE’s Current Ratio compared to its peers?

Neurogene Inc.’s Current Ratio is greater than Lineage Cell Therapeutics, Inc. (4.50), greater than Ocugen, Inc. (1.83), greater than Fulcrum Therapeutics, Inc. (17.70), greater than Autolus Therapeutics plc (8.43), greater than ADC Therapeutics S.A. (4.93), less than Benitec Biopharma Inc. (46.95), greater than Solid Biosciences Inc. (6.74), greater than PureTech Health plc (8.49), greater than Quantum-Si incorporated (9.43), greater than Alumis Inc. Common Stock (6.01),

Build a custom stock screener for Neurogene Inc. (NGNE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neurogene Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neurogene Inc. (NGNE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neurogene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.